期刊文献+

98株肺炎链球菌耐药性调查 被引量:1

98 Strains of Streptococcus Pneumoniae Drug Resistance
暂未订购
导出
摘要 目的了解本院住院患者鼻咽部链球菌耐药性。方法对本院2008年1~12月分离的98株肺炎链球菌进行药敏试验。结果青霉素耐药率8.2%,苯唑西林耐药率77.6%,耐苯唑西林同时也耐红霉素、林可霉素。结论肺炎链球菌耐药性上升迅速,且耐药程度高。加强对肺炎链球菌耐药性监测,采取合理有效的用药措施,减小耐药株的产生,是细菌检验工作与医院感染监测工作的重要内容。 Objective To investigate inpatients with drug resistance of nasopharyngeal Streptococcus. Methods We carried out the susceptibility test of 98 isolated strains of Streptococcus pneumoniae from Jan 2008 to Dec 2008. Results The resistance rate of penicillin was 8.2%, the oxacillin resistance rate was 77.6%, and those resistant to oxacillin were also resistant to erythromyein and lineomyein. Conclusion The antimicrobial resistance of Streptococcus pneumoniae increases rapidly and its resistance was high. Therefore, Bacteriological examination work and nosocomial infection surveillance should cover the followings : strengthening the monitoring of antimicrobial resistance of Streptococcus pneumoniae and taking reasonable and effective drug measures to reduce production of resistant strains.
出处 《中国现代医生》 2010年第26期41-42,共2页 China Modern Doctor
关键词 链球菌 肺炎 耐药性 Streptococcus Pneumoniae Drug resistance
  • 相关文献

参考文献4

二级参考文献39

  • 1唐英春,中华结核和呼吸杂志,1998年,21卷,517页
  • 2Oster P, Zanchi A, Cresti S, et al. Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates. [J]. Antimicrob Agents Chemother, 1999, 43(10): 2510
  • 3Waites K, Johnson C, Gray B, et al. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. [J]. J Clin Microbiol, 2000, 38(5): 1731
  • 4Descheemaeker P, Chapelle S, Lammens C, et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. [J]. J Antimicrob Chemo-ther,2000,45(2): 167
  • 5Tait-Kamradt A, Clancy J, Cronan M, et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. [J]. Antimicrob Agents Chemother, 1997,41(10): 2251
  • 6Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. [J]. Antimicrob Agents Chemother, 1996, 40(8): 1817
  • 7Tait-Kamradt A, Davies T, Cronan M, et al. Mutation in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. [J]. Antimicrob Agents Chemother,2000, 44(8): 2118
  • 8Jones ME, Sahm DF, Martin N, et al. Prevalence of gyrA, gyrB, parC, and pare mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season. [J]. Antimicrob Agents Chemother, 2000, 44(2): 462
  • 9Divies TD, Pankuch GA, Dewasse BE, et al. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. [J]Antimicrob Agents Chemother, 1999, 43(5): 1177
  • 10Broskey J, Coleman K, Gwynn MN, et al. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae. [J]. J Antimicrob Chemother, 2000,45(Suppl S1): 95

共引文献225

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部